Ray Dalio's OMCL Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 158,638 shares of Omnicell, Inc. (OMCL) worth $5.4 M, representing 0.02% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in OMCL, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 100,924 shares. Largest reduction occurred in Q2 2022, reducing 50,377 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Omnicell (OMCL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Omnicell (OMCL) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +100,924 | Add 174.87% | 158,638 | $34.05 |
| Q2 2026 | +57,714 | New Buy | 57,714 | $41.52 |
| Q1 2025 | -4,959 | Sold Out | 0 | $0.00 |
| Q4 2024 | -12,970 | Reduce 72.34% | 4,959 | $44.52 |
| Q3 2024 | -20,357 | Reduce 53.17% | 17,929 | $43.60 |
| Q2 2024 | -3,325 | Reduce 7.99% | 38,286 | $27.07 |
| Q1 2024 | -6,661 | Reduce 13.80% | 41,611 | $29.23 |
| Q4 2023 | +36,838 | Add 322.18% | 48,272 | $37.63 |
| Q3 2023 | -37,369 | Reduce 76.57% | 11,434 | $45.04 |
| Q2 2023 | -5,483 | Reduce 10.10% | 48,803 | $73.67 |
| Q1 2023 | +2,346 | Add 4.52% | 54,286 | $58.67 |
| Q4 2022 | -17,252 | Reduce 24.93% | 51,940 | $50.42 |
| Q3 2022 | -406 | Reduce 0.58% | 69,192 | $87.03 |
| Q2 2022 | -50,377 | Reduce 41.99% | 69,598 | $113.75 |
| Q1 2022 | +29,591 | Add 32.74% | 119,975 | $129.49 |
| Q4 2021 | +15,368 | Add 20.49% | 90,384 | $180.44 |
| Q3 2021 | -1,920 | Reduce 2.50% | 75,016 | $148.44 |
| Q2 2021 | +72,948 | Add 1829.19% | 76,936 | $151.45 |
| Q1 2021 | +3,988 | New Buy | 3,988 | $129.89 |
Ray Dalio's Omnicell Investment FAQs
Ray Dalio first purchased Omnicell, Inc. (OMCL) in Q1 2021, acquiring 3,988 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Omnicell, Inc. (OMCL) for 19 quarters since Q1 2021.
Ray Dalio's largest addition to Omnicell, Inc. (OMCL) was in Q3 2026, adding 158,638 shares worth $5.4 M.
According to the latest 13F filing for Q3 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 158,638 shares of Omnicell, Inc. (OMCL), valued at approximately $5.4 M.
As of the Q3 2026 filing, Omnicell, Inc. (OMCL) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Omnicell, Inc. (OMCL) was 158,638 shares, as reported at the end of Q3 2026.